SCHEMBL6950005

SCHEMBL6950005

COc1ccc(N(c2ccc(OC)cc2OC)S(=O)(=O)c2ccc(CBr)cc2)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 5/20 0.47
NFE2L2 Q16236 4/20 0.47
HTT P42858 2/20 0.47
LMNA P02545 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TAS2R14 Q9NYV8 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
BMP1 P13497 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 2/20 0.40
TSHR P16473 1/20 0.40
POLB P06746 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
DRD2 P14416 1/20 0.40
DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7829381 0.82 MAPT (0.52) KEAP1NFE2L2LMNATAS2R14MAPT
SCHEMBL2109904 0.73 TAS2R14 (0.68) TAS2R14MAPT
SCHEMBL9390270 0.72 PKM (0.70) SMN1; SMN2ALDH1A1
SCHEMBL21773447 0.70 BMP1 (0.59) KEAP1NFE2L2TAS2R14BMP1
SCHEMBL28206910 0.69 IDO1 (0.56) SMN1; SMN2MAPTALDH1A1TSHR
SCHEMBL5893516 0.68 CYP1A1 (0.57) SMN1; SMN2MAPTKMT2A
SCHEMBL28654739 0.67 IDO1 (0.58) SMN1; SMN2MAPTALDH1A1TSHR
SCHEMBL2883 0.67 IDO1 (0.58) SMN1; SMN2MAPTALDH1A1TSHR
SCHEMBL2468075 0.67 LMNA (0.66) HTTLMNAL3MBTL1SMN1; SMN2MAPT
SCHEMBL21646291 0.67 SMN1; SMN2 (0.46) HTTLMNATAS2R14SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115729-B1 PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PTP-1B MERCK FROSST CANADA INC (CA) 2003-02-19 EP disclosed
US-6174874-B1 ANTIDIABETIC,-CARCINOGENIC AGENTS; IMPROVING GLUCOSE TOLERANCE/INSULIN-SENSITIVITY; PREVENTING/TREATING OBESITY AND NEURODEGENERATIVE DISEASES; E.G. 1,3-BIS-((PHOSPHONODI-FLUOROMETHYL)PHENYL)-2-DICARBOXYPROPANE MERCK FROSST CANADA & CO. (CA) 2001-01-16 US disclosed